API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/06/04/2893354/0/en/Crossject-announces-highly-successful-closing-of-its-8-million-rights-offering.html
https://www.globenewswire.com/news-release/2024/05/30/2890498/0/en/Crossject-announces-publication-of-clinical-data-on-ZEPIZURE-in-Neurology-and-Therapy.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf
https://www.prnewswire.com/news-releases/nayzilam-midazolam-results-published-in-epilepsy--behavior-examining-the-impact-of-dose-on-return-to-full-baseline-function-rtfbf-for-people-with-seizure-clusters-301972110.html
https://www.fiercepharma.com/pharma/specialty-injectables-maker-exela-issues-recall-after-particles-turn-3-different-drugs
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.prnewswire.com/news-releases/neuraxpharm-completes-its-presence-in-benelux-by-opening-an-affiliate-in-brussels-to-cover-belgium-and-luxembourg-301728349.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216048
https://www.prnewswire.com/news-releases/rafa-receives-fda-approval-for-life-saving-midazolam-autoinjector-301614545.html
https://www.globenewswire.com/news-release/2022/06/18/2464968/0/en/CROSSJECT-Agreement-with-BARDA-on-ZENEO-Midazolam.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-5-2022-1641361383.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-midazolam-intravenous-1635917427.pdf
https://endpts.com/fda-warns-minnesota-doc-for-running-two-ketamine-trials-without-inds-and-with-children-and-a-pregnant-woman/
https://www.contractpharma.com/contents/view_breaking-news/2020-04-20/wavelength-ups-api-production-for-essential-respiratory-meds/
https://www.biospace.com/article/releases/wavelength-pharmaceuticals-expands-supplies-of-key-drug-ingredients-for-critically-ill-covid-19-patients/
https://www.fiercepharma.com/manufacturing/coronavirus-demand-causes-shortages-hospital-anesthetics-painkillers
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Midazolam+Injection%2C+USP&st=c&tab=tabs-4&panels=0
https://www.raps.org/news-and-articles/news-articles/2020/4/fda-reports-shortage-of-sedation-drug-used-for-put
https://www.raps.org/news-and-articles/news-articles/2020/4/fda-reports-shortage-of-sedation-drug-used-for-put
https://www.prnewswire.com/news-releases/ucb-presents-new-data-demonstrating-commitment-to-epilepsy-at-2019-american-epilepsy-society-meeting-300969719.html
https://www.prnewswire.com/news-releases/ucb-announces-availability-of-nayzilam-midazolam-nasal-spray-civ-the-first-and-only-nasal-rescue-treatment-for-seizure-clusters-in-the-us-300964269.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf
https://www.prnewswire.com/news-releases/ucb-announces-nayzilam-midazolam-nasal-spray-now-approved-by-fda-to-treat-intermittent-stereotypic-episodes-of-frequent-seizure-activity-in-people-living-with-epilepsy-in-the-us-300852851.html
https://www.prnewswire.com/news-releases/ucb-announces-nayzilam-midazolam-nasal-spray-now-approved-by-fda-to-treat-intermittent-stereotypic-episodes-of-frequent-seizure-activity-in-people-living-with-epilepsy-in-the-us-300852851.html
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-25-2018-1532506531.pdf
https://www.in-pharmatechnologist.com/Article/2018/07/12/US-prison-fraudulently-obtained-sedative-for-lethal-injection-claims-Alvogen
https://www.prnewswire.com/news-releases/imprimis-pharmaceuticals-to-feature-its-patent-pending-cyclosporinechondroitin-sulfate-and-patented-non-opioid-mko-melt-midazolamketamineondansetron-formulations-at-the-upcoming-cataract--refractive-surgery-medical-meeting-300626616.html
https://www.biospace.com/article/imprimis-jumps-secures-patent-for-non-opioid-compound/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-10-2018-1515560737.pdf
https://www.pharmacompass.com/pdf/news/fresenius-kabi-issues-voluntary-nationwide-recall-of-midazolam-injection-usp-2-mg2-ml-1509770761.pdf
https://www.theguardian.com/us-news/2017/jul/07/virginia-executes-william-morva-using-controversial-three-drug-mixture
http://www.orlandosentinel.com/news/nationworld/ct-arkansas-lethal-injection-drugs-20170413-story.html
http://www.prnewswire.com/news-releases/sobi-and-horizon-pharma-enter-five-year-distribution-agreement-for-ravicti-and-ammonaps-outside-the-united-states-300374421.html
http://in.reuters.com/article/2015/08/12/us-usa-execution-arkansas-idINKCN0QH2QW20150812
http://blogs.wsj.com/pharmalot/2015/03/04/akorn-takes-steps-to-prohibit-its-drugs-from-being-used-for-executions/
http://www.bloomberg.com/news/articles/2015-01-26/lethal-injection-case-may-be-derailed-as-oklahoma-seeks-new-drug
http://www.businesswire.com/news/home/20150121005725/en/Research-Markets-China-Sleep-Disorder-Treatment-Drugs#.VMCL8NKUde8